s-hiv-1 oligopeptide-2 sp hamilelikte güvenli mi?

Related ingredients

Frequently asked questions

s-hiv-1 oligopeptide-2 sp hamilelikte güvenli mi?

No harmonised CLP classification (ECHA Annex VI), no CIR or SCCS safety assessment, and no peer‑reviewed reproductive/toxicity data identified for 's-hiv-1 oligopeptide-2 sp'. As a peptide-like cosmetic active it is expected to have low systemic hazard and CIR-style 'safe as used' default applies in absence of contrary data.

s-hiv-1 oligopeptide-2 sp emzirirken güvenli mi?

No evidence of reproductive or lactation toxicity, no harmonised CLP flags, and no published data indicating transfer into breastmilk. Peptides used topically typically have negligible systemic hazard in the absence of supporting data.

s-hiv-1 oligopeptide-2 sp bebek cildi için güvenli mi?

No infant-specific safety data found. Parent/adult hazard and mechanism none (see above). Exposure increased to 1 because topical peptides are large/polar but not guaranteed completely non‑absorbable; infant skin has higher absorption potential so a modest increase in exposure score is applied in absence of definitive dermal absorption data.

VeriMom s-hiv-1 oligopeptide-2 sp nasıl puanlıyor?

VeriMom s-hiv-1 oligopeptide-2 sp'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.

Hamilelikte s-hiv-1 oligopeptide-2 sp yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.